Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01562184
Recruitment Status :
First Posted : March 23, 2012
Last Update Posted : December 2, 2015
The University of New South Wales
Sheppard Pratt Health System
University of Medicine and Dentistry of New Jersey
Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression that has shown promising efficacy in four recent double-blind, randomized, sham-controlled trials (RCT) and a meta-analysis. This study is a RCT of tDCS in depressed patients, testing its efficacy in both unipolar and bipolar depression. Mood, cognitive test performance and biomarkers will be measured during the trial.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
18 years of age or above.
Meets criteria for a DSM-IV Major Depressive Episode with duration of at least 4 weeks.
Total score ≥ 20 on the Montgomery-Asberg Depression Rating Scale at study entry.
Current episode duration greater than 3 years.
Failed more than 3 adequate antidepressant trials in current episode.
DSM-IV psychotic disorder.
Drug or alcohol abuse or dependence (preceding 3 months).
Inadequate response to ECT in the current episode of depression.
Rapid clinical response required, e.g., high suicide risk.
Significant acute suicide risk, defined as follows: suicide attempt within the previous 6 months that required medical treatment; or ≥ 2 suicide attempts in the past 12 months; or has a clear-cut plan for suicide and states that they cannot guarantee that they will call their regular psychiatrist or the investigator if the impulse to implement the plan becomes substantial during the study; or in the investigator's opinion, is likely to attempt suicide within the next 6 months.
Clinically defined neurological disorder or insult.
Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.